Clinical Trials on 非髓系恶性肿瘤 in Japan
总计903个结果
-
Amgen终止复发/难治性急性髓系白血病 (AML)美国, 大韩民国, 澳大利亚, 日本, 德国, 加拿大
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study Group主动,不招人
-
Jichi Medical UniversityTakara Bio Inc.未知
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima Medical University; Kanagawa Cancer Center 和其他合作者未知
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
Kyowa Kirin Co., Ltd.终止
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
Kyowa Kirin Co., Ltd.完全的
-
Novartis Pharmaceuticals完全的骨髓增生异常综合征 (MDS) | 急性髓系白血病 (AML) | 慢性粒单核细胞白血病 (CMML)日本
-
Novartis Pharmaceuticals完全的
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Kobe City General Hospital终止
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo完全的
-
Astellas Pharma Global Development, Inc.完全的骨髓增生异常综合症 | 急性髓系白血病 (AML)美国, 日本
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan未知
-
Astex Pharmaceuticals, Inc.终止
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLC招聘中非小细胞肺癌 II 期 | 非小细胞肺癌 IB 期 | 非小细胞肺癌ⅢA期日本
-
Kyowa Kirin Co., Ltd.完全的
-
AbbVie招聘中
-
AstraZeneca完全的Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers日本
-
Hyogo Medical UniversityMerck Sharp & Dohme LLC尚未招聘
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, Japan终止